Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
05/2005
05/19/2005US20050107365 adrenoceptor or G-protein coupled receptors inhibitors such as 3-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-6,7-dimethoxy-2H-benzo[1,2,4]-thiadiazine-1,1-dioxide and carriers, used for prophylaxis of urogenital disorders, or as analgesics
05/19/2005US20050104042 Process for the synthesis of amine ethers from secondary amino oxides
05/19/2005DE10348044A1 Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen Dual-alanyl aminopeptidase and dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005DE10348023A1 Neue Alanyl-Aminopeptidasen-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New alanyl aminopeptidase inhibitors for functional interference of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/19/2005CA2551056A1 Benzo[b][1,4]dioxepine derivatives
05/19/2005CA2544678A1 Modulators of cellular adhesion
05/19/2005CA2543943A1 2-azetidinones as anti-hypercholesterolemic agents
05/19/2005CA2543643A1 Pyridine carboxylic acid derivatives as glucokinase modulators
05/19/2005CA2543602A1 Triazole compounds and uses related thereto
05/18/2005EP1531166A2 Cycloaliphatic epoxy compounds containing styrenic, cinnamyl, or maleimide functionality
05/18/2005EP1530567A1 Pyridinyl substituted (1,2,3,)triazoles as inhibitors of the tgf-beta signalling pathway
05/18/2005EP1530472A1 Isoquinoline derivatives as matrix metalloproteinase inhibitors
05/18/2005EP1467991B1 Prucalopride-n-oxide
05/18/2005EP1301502B1 Compounds and their use as glycine transport inhibitors
05/18/2005EP1250047B9 Herbicidal composition
05/18/2005EP1224195B1 C-aryl glucoside sglt2 inhibitors
05/18/2005EP1098885B9 Imidazole compounds and their use as adenosine deaminase inhibitors
05/18/2005CN1617859A 5-sulfanyl-4h-1, 2, 4-triazole derivatives and their use as a medicament
05/18/2005CN1617858A Pyrimidine derivatives as modulators of insulin-like growth factor-1 receptor (igf-1)
05/18/2005CN1617856A Substituted 4-phenyltetrahydroisoquinolinium, process for their preparation, their use as a medicament, and medicament containing them
05/18/2005CN1617855A Inhibitors of cytosolic phospholipase A2
05/18/2005CN1617852A Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
05/18/2005CN1617849A Hiv整合酶抑制剂 Hiv integrase inhibitors
05/18/2005CN1617726A N4-acylcytosine nucleosides for treatment of viral infections
05/18/2005CN1617718A N-aryl-N'-arylcycloalkyl-urea derivatives as MCH antagonists for the treatment of obesity
05/18/2005CN1615853A Enhancement of bone growth and inhibition of bone resorption
05/18/2005CN1202108C Spiro compounds, preparing method and intermediate
05/18/2005CN1202107C 2-(4-methiopnoxy)-5-furfural imidazolone derivative with bactericiding activity
05/18/2005CN1202104C 2-phenylpyran-4-one derivatives
05/18/2005CN1202095C Heteroaromatic ring compounds
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202087C Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
05/17/2005US6894177 Viricides; human immunodeficiency virus
05/17/2005US6894173 Intermediates useful for synthesis of heteroaryl-substituted urea compounds, and processes of making same
05/17/2005US6894164 Process for the preparation of (pyridinylidene)-phthalides
05/17/2005US6894072 Compounds as NS3-serine protease inhibitors of hepatitis C virus
05/17/2005US6894067 5-heteroatom-substituted pyrazoles
05/17/2005US6894065 For therapy of thrombosis, platelet aggregation, coagulation, cancer, inflammatory diseases or respiratory diseases
05/17/2005US6894061 Substituted dihydrophenanthridinesulfonamides
05/17/2005US6894050 3,4,5,6-tetrahydro-2h-(1,2')bipyrazinyl derivatives
05/17/2005US6894047 Triazine compounds useful as sorbitol dehydrogenase inhibitors
05/17/2005US6894042 Azabicyclic compounds for the treatment of disease
05/17/2005US6893859 Antiproliferative agent for treating diseases or conditions characterized by cellular hyperproliferation
05/17/2005CA2306782C Isoquinolines as urokinase inhibitors
05/17/2005CA2301967C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2301543C Azetidinone derivatives for the treatment of hcmv infections
05/17/2005CA2252907C Novel 2,3 disubstituted-4(3h)-quinazolinones
05/12/2005WO2005042533A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors
05/12/2005WO2005042524A1 Pyridine carboxamide and methods for inhibiting hiv integrase
05/12/2005WO2005042522A1 Process for the manufacture of the calcium salt of rosuvatatin (e)-7-`4- (4-fluorophenyl) -6-isopropyl-2-`methyl (methylsulfonyl) amino ! pyrimidin -5-yl ! (3r, 5s) -3, 5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof
05/12/2005WO2005042521A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005WO2005042502A1 Amide derivatives
05/12/2005WO2005042500A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/12/2005WO2005042497A2 Benzimidazoles useful as modulators of ion channels
05/12/2005WO2005042496A1 (benzimidazol-2-yl)-phenyl-benzyl-amine derivatives and methods for inhibiting heparanase activity
05/12/2005WO2005042489A1 N-substituted benzene sulfonamides
05/12/2005WO2005042488A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005WO2005042487A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042486A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005WO2005042464A1 Androgen receptor modulators
05/12/2005WO2005019209A3 Crystalline anhydrous paroxetine hydrochloride
05/12/2005WO2005018531A3 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof
05/12/2005WO2005014539A3 Pyrrole-based hmg-coa reductase inhibitors
05/12/2005WO2005003100A3 4-arylamino-quinazolines as activators of caspases and inducers of apoptosis
05/12/2005WO2005003099A3 Pyrimidines useful as modulators of voltage-gated ion channels
05/12/2005WO2004092145A8 Alpha substituted carboxylic acid as ppar modulators
05/12/2005US20050101781 Eponemycin and epoxomicin analogs and uses thereof
05/12/2005US20050101779 Antagonistic activity to alpha 4 integrin; antiinflammatory agents treating asthma, rheumatoid arthritis, inflammatory bowel diseases, lupus, diabetes; 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl(2S)-2-[(2,6-dichlorobenzoyl)amino]-3-[4-[1-methyl-2,4-dioxo-1,4-tetrahydro-3-(2H)quinazolinyl]phenyl]Propionate
05/12/2005US20050101776 2' or 3' -deoxy and 2' , 3' -dideoxy-beta-L-pentofuranonucleo-side compounds, method of preparation and application in therapy, especially as anti-viral agents
05/12/2005US20050101657 Pyrrole derivatives for preventing or treating cancer sensitive to hormones; administered with luteininzing hormone releasing hormone derivative
05/12/2005US20050101651 Viricides; protease inbhibitors; useful for inhibiting the activity of picornaviral 3C proteases; for example, 6-carbamoyl-4S-{2S-[(5-naphthalen-1-yl-1H-pyrrole-2-carbonyl)-amino-3-phenyl-propionylamino}-hex-2(trans)-enoic acid ethyl ester
05/12/2005US20050101650 (4-(4-(2,3-difluorophenyl)-4H-1,2,4-triazol-3-yl)-1H-pyrrol-2-yl)(2H-pyrrol-1(5H)-yl)methanone; anticarcinogenic, antiproliferative and antimetastasis agent; inhibitors of c-Met protein kinase
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101641 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/12/2005US20050101634 Bis(5-aeyl-2-pyridyl) derivatives
05/12/2005US20050101630 4-Anilino-, phenoxy-, or phenylthio-substituted; inhibitors of specific kinase enzymes, such as MEK enzymes
05/12/2005US20050101617 Cyanoguanidines and cyanoamidines as ErbB2 and EGFR inhibitors
05/12/2005US20050101614 Heterocyclic GABAA subtype selective receptor modulators
05/12/2005US20050101590 Cannabinoid receptor agonists
05/12/2005US20050101584 Selective estrogen receptor-beta ligands
05/12/2005US20050101568 Methods and compositions for selectin inhibition
05/12/2005US20050101567 Using a sulfonamide containing compound
05/12/2005US20050101540 STAT modulators
05/12/2005US20050100978 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors
05/12/2005CA2544772A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005CA2544763A1 1,4-dihydropyridine compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease
05/12/2005CA2544350A1 N-substituted benzene sulfonamides
05/12/2005CA2543918A1 Benzimidazoles useful as modulators of ion channels
05/12/2005CA2543715A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
05/12/2005CA2543533A1 2-cyanopyrrolidinecarboxamide compound
05/12/2005CA2543529A1 Pyridine compounds as inhibitors of dipeptidyl peptidase iv
05/12/2005CA2543358A1 Process for the manufacture of the calcium salt of rosuvastatin(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3r,5s)-3,5-dihydroxyhept-6-enoic acid and crystalline intermediates thereof
05/12/2005CA2543345A1 Androgen receptor modulators
05/12/2005CA2540686A1 Arylindenopyridines and arylindenopyridines and their use as adenosine a2a receptor antagonist
05/11/2005EP1529530A1 Compounds affecting glucokinase
05/11/2005EP1529044A2 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
05/11/2005EP1529042A1 Arylamides
05/11/2005EP1528925A1 Quinazoline derivatives for use in the treatment of cancer
05/11/2005EP1528924A1 Mch1r antagonists
05/11/2005EP1363899B1 Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists
1 ... 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 ... 694